Literature DB >> 2187192

Transforming growth factor beta 1 suppression of c-myc gene transcription: role in inhibition of keratinocyte proliferation.

J A Pietenpol1, J T Holt, R W Stein, H L Moses.   

Abstract

Transforming growth factor beta 1 (TGF-beta 1) is a potent growth inhibitor for many cell types, including most epithelial cells. However, the mechanism of growth inhibition is unknown. In skin keratinocytes, TGF-beta 1 has been shown to inhibit growth and to rapidly reduce c-myc expression. It has been demonstrated that protein synthesis is required for TGF-beta 1 regulation of c-myc in keratinocytes. Here we present evidence that treatment of mouse BALB/MK keratinocyte cells with either antisense c-myc oligonucleotides or TGF-beta 1 inhibited cell entry into S phase. These results suggest that TGF-beta inhibition of c-myc expression may be essential for growth inhibition by TGF-beta 1. The block in c-myc expression by TGF-beta 1 occurred at the level of transcriptional initiation. Studies with a series of 5' deletion c-myc/chloramphenicol acetyltransferase constructs indicated that a cis regulatory element(s), which resides between positions -100 and +71 relative to P1 transcription start site, is responsible for the TGF-beta 1 responsiveness. Based on these data, it is proposed that the mechanism of TGF-beta 1 growth inhibition involves synthesis or modification of a protein that may interact with a specific element(s) in the 5' regulatory region of the c-myc gene, resulting in inhibition of transcriptional initiation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2187192      PMCID: PMC53982          DOI: 10.1073/pnas.87.10.3758

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Reversible inhibition of normal human prokeratinocyte proliferation by type beta transforming growth factor-growth inhibitor in serum-free medium.

Authors:  G D Shipley; M R Pittelkow; J J Wille; R E Scott; H L Moses
Journal:  Cancer Res       Date:  1986-04       Impact factor: 12.701

2.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

3.  Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene.

Authors:  M E Greenberg; E B Ziff
Journal:  Nature       Date:  1984 Oct 4-10       Impact factor: 49.962

4.  Identification of two distinct regulatory regions adjacent to the human beta-interferon gene.

Authors:  K Zinn; D DiMaio; T Maniatis
Journal:  Cell       Date:  1983-10       Impact factor: 41.582

5.  Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes.

Authors:  H Land; L F Parada; R A Weinberg
Journal:  Nature       Date:  1983 Aug 18-24       Impact factor: 49.962

6.  Molecular cloning of gene sequences regulated by platelet-derived growth factor.

Authors:  B H Cochran; A C Reffel; C D Stiles
Journal:  Cell       Date:  1983-07       Impact factor: 41.582

7.  BALB and Kirsten murine sarcoma viruses alter growth and differentiation of EGF-dependent balb/c mouse epidermal keratinocyte lines.

Authors:  B E Weissman; S A Aaronson
Journal:  Cell       Date:  1983-02       Impact factor: 41.582

8.  Human transforming growth factor-beta 3: recombinant expression, purification, and biological activities in comparison with transforming growth factors-beta 1 and -beta 2.

Authors:  J L Graycar; D A Miller; B A Arrick; R M Lyons; H L Moses; R Derynck
Journal:  Mol Endocrinol       Date:  1989-12

9.  Type beta transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells.

Authors:  T Masui; L M Wakefield; J F Lechner; M A LaVeck; M B Sporn; C C Harris
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

10.  Sequence of the murine and human cellular myc oncogenes and two modes of myc transcription resulting from chromosome translocation in B lymphoid tumours.

Authors:  O Bernard; S Cory; S Gerondakis; E Webb; J M Adams
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  95 in total

1.  LXRalpha functions as a cAMP-responsive transcriptional regulator of gene expression.

Authors:  K Tamura; Y E Chen; M Horiuchi; Q Chen; L Daviet; Z Yang; M Lopez-Ilasaca; H Mu; R E Pratt; V J Dzau
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

Review 2.  TGF-beta: problems and prospects.

Authors:  M B Sporn; A B Roberts
Journal:  Cell Regul       Date:  1990-11

3.  Evidence for the involvement of protein kinase activity in transforming growth factor-beta signal transduction.

Authors:  M Ohtsuki; J Massagué
Journal:  Mol Cell Biol       Date:  1992-01       Impact factor: 4.272

4.  Evaluation of the role of extracellular matrix proteins, polyunsaturated fatty acids and c-myc expression in the inhibition of the serum-free growth of epithelial cells by TGF-beta 1.

Authors:  D J Sarubbi; R Narayanan; N T Telang; M J Newman
Journal:  In Vitro Cell Dev Biol       Date:  1990-12

5.  Cloning of a growth arrest-specific and transforming growth factor beta-regulated gene, TI 1, from an epithelial cell line.

Authors:  B Kallin; R de Martin; T Etzold; V Sorrentino; L Philipson
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

6.  A crosstalk between TGF-β/Smad3 and Wnt/β-catenin pathways promotes vascular smooth muscle cell proliferation.

Authors:  Daniel M DiRenzo; Mirnal A Chaudhary; Xudong Shi; Sarah R Franco; Joshua Zent; Katie Wang; Lian-Wang Guo; K Craig Kent
Journal:  Cell Signal       Date:  2016-02-19       Impact factor: 4.315

7.  Characterization of a human hepatoma cell line with acquired resistance to growth inhibition by transforming growth factor beta 1 (TGF-beta 1).

Authors:  K Hasegawa; Z Wang; M Inagaki; B I Carr
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-01       Impact factor: 2.416

8.  Transforming growth factor beta 1-responsive element: closely associated binding sites for USF and CCAAT-binding transcription factor-nuclear factor I in the type 1 plasminogen activator inhibitor gene.

Authors:  A Riccio; P V Pedone; L R Lund; T Olesen; H S Olsen; P A Andreasen
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

9.  Interferons and interleukin-6 suppress the DNA-binding activity of E2F in growth-sensitive hematopoietic cells.

Authors:  D Melamed; N Tiefenbrun; A Yarden; A Kimchi
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

10.  MYC Is a Crucial Mediator of TGFβ-Induced Invasion in Basal Breast Cancer.

Authors:  Magdalena A Cichon; Megan E Moruzzi; Tiziana A Shqau; Erin Miller; Christine Mehner; Stephen P Ethier; John A Copland; Evette S Radisky; Derek C Radisky
Journal:  Cancer Res       Date:  2016-04-13       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.